NCT07187882 Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo
| NCT ID | NCT07187882 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University People's Hospital |
| Condition | Vitiligo |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-04-25 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-04-25 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To observe the long-term efficacy and safety of autologous non cultured epidermal cell suspension transplantation in the treatment of vitiligo, analyze the correlation between cell density, type, and postoperative efficacy and prognosis, and providing a basis for clinical application.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed as vitiligo, according to the "Vitiligo Diagnosis and Treatment Consensus (2021 edition) * Segmental and unclassified vitiligo stable for 6 months, Non-segmental vitiligo stable for 1 year and resistant to medication and phototherapy * BSA≥5% * Sign the informed consent and be willing to undergo surgical treatment * 8-65 years old, both genders Exclusion Criteria: * Severe visceral or infectious disease not suitable for surgical treatment * Tendency toward keloid formation * Coagulation defects * Unable to complete follow-up on time
Frequently Asked Questions
Who can join the NCT07187882 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 65 Years, studying Vitiligo. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07187882 currently recruiting?
Yes, NCT07187882 is actively recruiting participants. Visit ClinicalTrials.gov or contact Peking University People's Hospital to inquire about joining.
Where is the NCT07187882 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07187882 clinical trial?
NCT07187882 is sponsored by Peking University People's Hospital. The trial plans to enroll 30 participants.